Rabin Martin

  • Newsletter Sign-Up
  • Twitter
  • LinkedIn
Menu
  • HOME
  • OUR FIRM
    • About Us
    • Diversity & Inclusion
    • Job Openings
    • News
  • OUR WORK
    • Expertise
    • Case Studies
    • Our Clients
    • SPARK
  • OUR PRODUCTS
    • LiGHT
  • TEAM
  • OUR INSIGHTS
    • Briefings
    • Blog
    • Reports
  • CONTACT US
  • NEWSLETTER SIGN-UP

Our Clients

  • Email
  • Print
  • Plus

• AbbVie

• Amgen

• AstraZeneca

• BD

• Biogen

• Children’s Investment Fund Foundation

• Center for Strategic & International Studies

• Bill & Melinda Gates Foundation

• Gavi, the Vaccine Alliance

• Gilead

• International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

• Johnson & Johnson

• Eli Lilly

• Merck KGaA

• Merck & Co., Inc.

• New York Academy of Medicine

• Novartis

• Novo Nordisk

• Pharmaceutical Research and Manufacturers of America (PhRMA)

• Pfizer

• Private Sector Roundtable for Global Health Security

• Robert Wood Johnson Foundation

• Roche

• Rockefeller Foundation

• Sanofi

• Takeda

• Teva

• UCB

• United Nations Children’s Fund (UNICEF)

• U.S. Pharmacopeial Convention

 

Selection of Partners

• U.S. Centers for Disease Control and Prevention

• GMHC

• Harvard T.H. Chan School of Public Health

• Jhpiego

• London School of Hygiene and Tropical Medicine

• NCD Alliance

• President’s Emergency Plan for AIDS Relief (PEPFAR)

• Union for International Cancer Control (UICC)

• World Health Organization

• World Bank

  • Email
  • Print
  • Plus
  • Contact us
  • Privacy Policy
  • Twitter
  • LinkedIn

All Rights Reserved Rabin Martin © 2023

Scroll up

Thanks for your interest!

Please just tell us a bit about yourself to download your requested report without delay.

Fields with * are mandatory.

We respect your privacy